MA49758A - Systèmes et procédés pour effectuer un dosage du glycane en temps réel d'un échantillon - Google Patents

Systèmes et procédés pour effectuer un dosage du glycane en temps réel d'un échantillon

Info

Publication number
MA49758A
MA49758A MA049758A MA49758A MA49758A MA 49758 A MA49758 A MA 49758A MA 049758 A MA049758 A MA 049758A MA 49758 A MA49758 A MA 49758A MA 49758 A MA49758 A MA 49758A
Authority
MA
Morocco
Prior art keywords
real
sample
systems
methods
glycan assay
Prior art date
Application number
MA049758A
Other languages
English (en)
Inventor
Chao-Hsiang Wu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MA49758A publication Critical patent/MA49758A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8804—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 automated systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MA049758A 2017-08-01 2018-08-01 Systèmes et procédés pour effectuer un dosage du glycane en temps réel d'un échantillon MA49758A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762539798P 2017-08-01 2017-08-01

Publications (1)

Publication Number Publication Date
MA49758A true MA49758A (fr) 2020-06-10

Family

ID=63350601

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049758A MA49758A (fr) 2017-08-01 2018-08-01 Systèmes et procédés pour effectuer un dosage du glycane en temps réel d'un échantillon

Country Status (16)

Country Link
US (2) US12025618B2 (fr)
EP (1) EP3662288B1 (fr)
JP (1) JP7184819B2 (fr)
KR (1) KR102577670B1 (fr)
CN (1) CN110892267B (fr)
AU (1) AU2018312564B2 (fr)
BR (1) BR112020001922A2 (fr)
CL (1) CL2020000250A1 (fr)
EA (1) EA202090380A1 (fr)
ES (1) ES2978397T3 (fr)
IL (1) IL271500B2 (fr)
MA (1) MA49758A (fr)
MX (1) MX2020001171A (fr)
SG (1) SG11202000785VA (fr)
WO (1) WO2019028191A1 (fr)
ZA (1) ZA202001214B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201907422RA (en) 2017-02-17 2019-09-27 Denali Therapeutics Inc Anti-tau antibodies and methods of use thereof
JP7483731B2 (ja) * 2019-02-14 2024-05-15 アムジエン・インコーポレーテツド 試料の調製及びその試料のリアルタイムアッセイの実施のためのシステム及び方法
US20230242655A1 (en) 2019-12-03 2023-08-03 Evotec International Gmbh Interferon-associated antigen binding proteins and uses thereof
GB202003336D0 (en) * 2020-03-06 2020-04-22 National Institute For Bioprocesisng Res And Training A system for producing a biopharmaceutical product
US12110324B2 (en) 2022-07-22 2024-10-08 Flagship Pioneering Innovations Vi, Llc Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
EP4476542A4 (fr) * 2023-04-28 2025-08-13 Vulcan Photonics Sdn Bhd Plaque de chromatographie millifluidique

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264327A (en) * 1978-04-21 1981-04-28 Blum Alvin S Method and apparatus for automatic competitive binding analysis
JPH0269655A (ja) * 1988-09-05 1990-03-08 Japanese Res & Dev Assoc Bio Reactor Syst Food Ind バイオリアクターオンライン自動分析装置
JPH05227943A (ja) * 1991-07-26 1993-09-07 Nippon Millipore Kogyo Kk 自動培養装置
CA2120327A1 (fr) * 1991-09-30 1993-04-15 Noubar B. Afeyan Systeme de chromatographie pour proteines
CA2146177C (fr) 1995-04-03 2000-09-05 Adrian P. Wade Reseau d'analyse de flux intelligent
US6887429B1 (en) * 2001-01-26 2005-05-03 Global Fia Apparatus and method for automated medical diagnostic tests
RS51829B (sr) 2001-08-23 2012-02-29 Genmab A/S. Ljudska antitela specifična za interleukin 15 (il-15)
US20030095897A1 (en) * 2001-08-31 2003-05-22 Grate Jay W. Flow-controlled magnetic particle manipulation
US20040009567A1 (en) 2001-12-28 2004-01-15 Mds Proteomics Inc. Enzyme/chemical reactor based protein processing method for proteomics analysis by mass spectrometry
US20040053356A1 (en) * 2001-12-28 2004-03-18 Mds Proteomics Inc. Enzyme/chemical reactor based protein processing method for proteomics analysis by mass spectrometry
EP1499643A4 (fr) * 2002-04-30 2008-04-16 Biowhittaker Technologies Inc Systemes automatises d'analyse d'injections sequentielles servant a determiner des niveaux d'endotoxine a l'etat de traces
US20040009597A1 (en) 2002-07-03 2004-01-15 Isis Pharmaceuticals Inc. Antisense modulation of PTPRK expression
US7906625B2 (en) 2005-01-24 2011-03-15 Amgen Inc. Humanized anti-amyloid antibody
US8003108B2 (en) 2005-05-03 2011-08-23 Amgen Inc. Sclerostin epitopes
US7592429B2 (en) 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
US8298763B2 (en) * 2007-03-02 2012-10-30 Lawrence Livermore National Security, Llc Automated high-throughput flow-through real-time diagnostic system
CN102027012A (zh) 2007-06-20 2011-04-20 Irm责任有限公司 用于治疗变应性疾病的方法和组合物
AU2008291358A1 (en) * 2007-08-31 2009-03-05 F. Hoffmann-La Roche Ag Glycosylation profile analysis
US7982016B2 (en) 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
TWI516501B (zh) 2008-09-12 2016-01-11 禮納特神經系統科學公司 Ｐｃｓｋ９拮抗劑類
WO2012037407A1 (fr) 2010-09-17 2012-03-22 Prozyme, Inc. Isolation et déglycosylation des glycoprotéines
US20140030732A1 (en) 2012-07-25 2014-01-30 Agilent Technologies, Inc. Microfluidic hplc-chip for glycopeptide analysis with integrated hilic enrichment
US9322014B1 (en) 2012-11-28 2016-04-26 Sandia Corporation Multiplexed microfluidic approach for nucleic acid enrichment
ES2978396T3 (es) 2017-08-01 2024-09-11 Amgen Inc Sistemas y métodos para la preparación en tiempo real de una muestra de polipéptidos para el análisis por espectrometría de masas
JP7483731B2 (ja) 2019-02-14 2024-05-15 アムジエン・インコーポレーテツド 試料の調製及びその試料のリアルタイムアッセイの実施のためのシステム及び方法

Also Published As

Publication number Publication date
KR20200035987A (ko) 2020-04-06
US20250003975A1 (en) 2025-01-02
JP7184819B2 (ja) 2022-12-06
IL271500A (en) 2020-02-27
WO2019028191A9 (fr) 2020-01-09
ES2978397T3 (es) 2024-09-11
EP3662288A1 (fr) 2020-06-10
WO2019028191A1 (fr) 2019-02-07
BR112020001922A2 (pt) 2020-08-04
US20200240993A1 (en) 2020-07-30
KR102577670B1 (ko) 2023-09-12
IL271500B2 (en) 2024-10-01
EP3662288B1 (fr) 2024-02-28
US12025618B2 (en) 2024-07-02
ZA202001214B (en) 2025-04-30
CN110892267B (zh) 2024-08-09
IL271500B1 (en) 2024-06-01
CA3071636A1 (fr) 2019-02-07
EA202090380A1 (ru) 2020-05-21
AU2018312564B2 (en) 2025-03-06
JP2020530101A (ja) 2020-10-15
CN110892267A (zh) 2020-03-17
SG11202000785VA (en) 2020-02-27
AU2018312564A1 (en) 2020-01-30
MX2020001171A (es) 2020-03-12
CL2020000250A1 (es) 2020-08-21

Similar Documents

Publication Publication Date Title
MA49758A (fr) Systèmes et procédés pour effectuer un dosage du glycane en temps réel d'un échantillon
EP3797394A4 (fr) Systèmes et procédés informatisés pour processus de pointé assisté
EP3452695A4 (fr) Procédés et systèmes pour l'analyse de réservoirs à fracturation hydraulique
EP3759682A4 (fr) Systèmes et procédés d'évaluation et de distribution automatisées de contenus
EP3458953A4 (fr) Systèmes et procédés d'analyse de logiciel basée sur un modèle
EP3794368A4 (fr) Systèmes et procédés de détection d'objets
EP3455730A4 (fr) Systèmes et procédés d'analyse de logiciel basée sur un modèle
EP3542289A4 (fr) Systèmes et procédés d'imagerie en temps réel
EP3430410A4 (fr) Systèmes et procédés pour analyse automatisée
EP3659117A4 (fr) Systèmes et procédés pour animations et interactivité de personnages complexes en temps réel
EP3774005A4 (fr) Systèmes et procédés pour des processus d'émulsion à écoulement série
EP3744083A4 (fr) Systèmes et procédés permettant de déterminer des paramètres d'exposition
EP3479293A4 (fr) Systèmes et procédés permettant d'effectuer le suivi du regard
EP3353645A4 (fr) Systèmes et procédés de distillation automatiques de concepts à partir de problèmes mathématiques et construction et test dynamiques de problèmes mathématiques à partir d'un ensemble de concepts mathématiques
EP3443485A4 (fr) Systèmes et procédés pour la détermination de point d'intérêt
EP3682024A4 (fr) Procédés et systèmes pour le traitement automatique d'échantillon
EP3665187A4 (fr) Procédés de dosage pour la détection améliorée d'analytes
EP3727693A4 (fr) Procédés et dispositifs de détection d'analytes multiples à partir d'un échantillon biologique
EP4004858A4 (fr) Systèmes, procédés et dispositifs pour générer une analyse en temps réel
EP3481272A4 (fr) Systèmes et procédés d'imagerie pour radiogénomique du cancer entraînée par particules, basée sur connaissances et prédictive
EP3510241A4 (fr) Systèmes et procédés d'actionnement de dispositifs à actionnement hydraulique
EP3698548A4 (fr) Systèmes et procédés pour améliorer la résolution de transition d'estampilles temporelles
EP3794590A4 (fr) Systèmes et procédés permettant de détecter et de rapporter un état d'enregistrement
EP3405926A4 (fr) Systèmes et procédés pour analyse d'image peropératoire
EP3956848A4 (fr) Systèmes et procédés de traitement en temps réel